DISSECTIONING RISK FACTORS FOR MYELODYSPLASTIC SYNDROME (MDS) AND ACUTE MYELOID LEUKEMIA (AML) AFTER AUTOTRANSPLANTS FOR PLASMA CELL MYELOMA AND LYMPHOMAS

被引：0
|
作者：
Hashmi, S. [1 ]
Dean, R. M. [2 ]
Shaw, B. [3 ]
Brazauskas, R. [3 ]
Millard, H. [3 ]
Battiwalla, M. [4 ]
Savani, B. [5 ]
Flowers, M. E. [6 ]
Cooke, K. R. [7 ]
Hamilton, B. K. [2 ]
Kalaycio, M. [8 ]
Radivoyevitch, T. [9 ]
Litzow, M. R. [10 ,11 ]
Gale, R. P. [12 ]
机构：
[1] Mayo Clin, Bone Marrow Transplant Program, Rochester, MN USA
[2] Taussig Canc Inst, Dept Hematol Oncol & Blood Disorders, Cleveland, OH USA
[3] MCW, CIBMTR, Milwaukee, WI USA
[4] NHLBI, Hematol Branch, Bethesda, MD 20892 USA
[5] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA
[6] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA
[7] Johns Hopkins Univ, Sidney Kimmel Canc Ctr, Pediat Blood & Marrow Transplantat Program, Baltimore, MD USA
[8] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA
[9] Cleveland Clin, Quantitat Hlth Sci, Cleveland, OH 44106 USA
[10] Mayo Clin, Div Hematol, Rochester, MN USA
[11] Mayo Clin, Transplant Ctr, Rochester, MN USA
[12] Imperial Coll London, Dept Med, Sect Hematol, London, England
来源：
LEUKEMIA RESEARCH | 2017年 / 55卷
关键词：
D O I：
10.1016/S0145-2126(17)30174-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
61
引用
收藏
页码：S41 / S41
页数：1
相关论文
共 50 条
  • [1] Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma
    Radivoyevitch, Tomas
    Dean, Robert M.
    Shaw, Bronwen E.
    Brazauskas, Ruta
    Tecca, Heather R.
    Molenaar, Remco J.
    Battiwalla, Minoo
    Savani, Bipin N.
    Flowers, Mary E. D.
    Cooke, Kenneth R.
    Hamilton, Betty K.
    Kalaycio, Matt
    Maciejewski, Jaroslaw P.
    Ahmed, Ibrahim
    Akpek, Gorgun
    Bajel, Ashish
    Buchbinder, David
    Cahn, Jean-Yves
    D'Souza, Anita
    Daly, Andrew
    DeFilipp, Zachariah
    Ganguly, Siddhartha
    Hamadani, Mehdi
    Hayashi, Robert J.
    Hematti, Peiman
    Inamoto, Yoshihiro
    Khera, Nandita
    Kindwall-Keller, Tamila
    Landau, Heather
    Lazarus, Hillard
    Majhail, Navneet S.
    Marks, David I.
    Olsson, Richard F.
    Seo, Sachiko
    Steinberg, Amir
    William, Basem M.
    Wirk, Baldeep
    Yared, Jean A.
    Aljurf, Mahmoud
    Abidi, Muneer H.
    Allewelt, Heather
    Beitinjaneh, Amer
    Cook, Rachel
    Cornell, Robert F.
    Fay, Joseph W.
    Hale, Gregory
    Chakrabarty, Jennifer Holter
    Jodele, Sonata
    Kasow, Kimberly A.
    Mahindra, Anuj
    LEUKEMIA RESEARCH, 2018, 74 : 130 - 136
  • [2] Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) after Multiple Myeloma: Assessment of Risk Factors
    Jonsdottir, Gudbjorg
    Bjorkholm, Magnus
    Turesson, Ingemar
    Hultcrantz, Malin
    Porwit, Anna
    Jethava, Yogesh
    Landgren, Ola
    Kristinsson, Sigurdur Y.
    BLOOD, 2017, 130
  • [3] Symptom Burden In Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
    Williams, Loretta A.
    Ault, Patricia S.
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    Quintas-Cardama, Alfonso
    Borthakur, Gautam
    Faderl, Stefan H.
    Jabbour, Elias J.
    Cleeland, Charles S.
    Cortes, Jorge E.
    BLOOD, 2013, 122 (21)
  • [4] Lenalidomide and Risk of Acute Myeloid Leukemia (AML) Transformation Among Myelodysplastic Syndrome (MDS) Patients
    Rollison, Dana E.
    Shain, Kenneth H.
    Lee, Ji-Hyun
    Hampras, Shalaka S.
    Fulp, William
    Fisher, Kate
    Al Ali, Najla H.
    Padron, Eric
    Lancet, Jeffrey
    Xu, Qiang
    Knight, Robert D.
    List, Alan F.
    Dalton, William
    Komrokji, Rami
    BLOOD, 2014, 124 (21)
  • [5] Myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in Down syndrome: Pathologic aspects
    Mast, K.
    Taub, J. W.
    Alonzo, T.
    Mosse, C.
    Gamis, A. S.
    Mathew, P.
    Jones, H.
    Hitzler, J.
    Head, D. R.
    LEUKEMIA RESEARCH, 2013, 37 : S89 - S90
  • [6] Comparison of Symptom Burden in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
    Williams, Loretta A.
    Ahaneku, Hycienth
    Cortes, Jorge E.
    Manero, Guillermo Garcia
    Kantarjian, Hagop M.
    Shi, Qiuling
    Lin, Huei-Kai
    Limaye, Achala R.
    Cleeland, Charles S.
    BLOOD, 2014, 124 (21)
  • [7] Prognostic factors for allogeneic stem cell transplantation (ASCT) for refractory acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS).
    Wong, R
    Shahjahan, M
    De Lima, M
    Anagnostopoulos, A
    Estey, E
    Champlin, R
    Andersson, B
    Khouri, I
    Giralt, S
    BLOOD, 2002, 100 (11) : 853A - 853A
  • [8] Treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) relapsing after allogeneic hematopoietic cell transplantation (HCT).
    Chiattone, A.
    Andersson, B.
    Bashir, Q.
    Landau, D.
    Rondon, G.
    Nieto, Y.
    Al Atrash, G.
    Giralt, S.
    Champlin, R. E.
    De Lima, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] Diagnostic of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
    Germing, Ulrich
    Haferlach, Torsten
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2015, 39 (05): : 291 - 299
  • [10] Erythropoietin (EPO)-dependent transformation of myelodysplastic syndrome (MDS) to acute myeloid leukemia (AML).
    Bunworasate, U
    Arnouk, H
    Minderman, H
    O'Loughlin, KL
    Sait, SNJ
    Barcos, M
    Baer, MR
    BLOOD, 2000, 96 (11) : 259B - 259B
12345